A citation-based method for searching scientific literature

Brittany A McKelvey, Timothy Gilpatrick, Yongchun Wang, Winston Timp, Christopher B Umbricht, Martha A Zeiger. Thyroid 2020
Times Cited: 4







List of co-cited articles
41 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.
Pedro Castelo-Branco, Sanaa Choufani, Stephen Mack, Denis Gallagher, Cindy Zhang, Tatiana Lipman, Nataliya Zhukova, Erin J Walker, Dianna Martin, Diana Merino,[...]. Lancet Oncol 2013
148
75

Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines.
Brittany A Avin, Yongchun Wang, Timothy Gilpatrick, Rachael E Workman, Isac Lee, Winston Timp, Christopher B Umbricht, Martha A Zeiger. Genes Chromosomes Cancer 2019
8
75


Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
50

Telomere length is related to alternative splice patterns of telomerase in thyroid tumors.
Yongchun Wang, Alan K Meeker, Jeanne Kowalski, Hua-Ling Tsai, Helina Somervell, Christopher Heaphy, Lauren E Sangenario, Nijaguna Prasad, William H Westra, Martha A Zeiger,[...]. Am J Pathol 2011
18
50


Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes.
Josh Lewis Stern, Richard D Paucek, Franklin W Huang, Mahmoud Ghandi, Ronald Nwumeh, James C Costello, Thomas R Cech. Cell Rep 2017
35
50

TERT promoter mutations and monoallelic activation of TERT in cancer.
F W Huang, C M Bielski, M L Rinne, W C Hahn, W R Sellers, F Stegmeier, L A Garraway, G V Kryukov. Oncogenesis 2015
38
50

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
512
50

Regulation of telomerase alternative splicing: a target for chemotherapy.
Mandy S Wong, Ling Chen, Christopher Foster, Radhika Kainthla, Jerry W Shay, Woodring E Wright. Cell Rep 2013
43
50

Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms.
Yongchun Wang, Jeanne Kowalski, Hua-Ling Tsai, Radharani Marik, Nijaguna Prasad, Helina Somervell, Pang-Kuo Lo, Lauren E Sangenario, Lars Dyrskjot, Torben F Orntoft,[...]. Thyroid 2008
31
50

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
379
50

The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity.
L M Colgin, C Wilkinson, A Englezou, A Kilian, M O Robinson, R R Reddel. Neoplasia 2000
178
50

Cancer-associated TERT promoter mutations abrogate telomerase silencing.
Kunitoshi Chiba, Joshua Z Johnson, Jacob M Vogan, Tina Wagner, John M Boyle, Dirk Hockemeyer. Elife 2015
142
50

Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma.
Na Wang, Dawei Xu, Anastasios Sofiadis, Anders Höög, Vladana Vukojević, Martin Bäckdahl, Jan Zedenius, Catharina Larsson. J Clin Endocrinol Metab 2014
26
50

Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer.
Eleni Mavrogiannou, Areti Strati, Aliki Stathopoulou, Emily G Tsaroucha, Loukas Kaklamanis, Evi S Lianidou. Clin Chem 2007
33
50

Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma.
Na Wang, Hanna Kjellin, Anastasios Sofiadis, Omid Fotouhi, C Christofer Juhlin, Martin Bäckdahl, Jan Zedenius, Dawei Xu, Janne Lehtiö, Catharina Larsson. Oncotarget 2016
29
50


Alternative splicing regulation of telomerase: a new paradigm?
Mandy S Wong, Woodring E Wright, Jerry W Shay. Trends Genet 2014
59
50

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
50


Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant.
Lisa F Lincz, Lisa-Maree Mudge, Fiona E Scorgie, Jennette A Sakoff, Christopher S Hamilton, Michael Seldon. Neoplasia 2008
44
50

Medical genetics and epigenetics of telomerase.
Jillian E Koziel, Melanie J Fox, Catherine E Steding, Alyssa A Sprouse, Brittney-Shea Herbert. J Cell Mol Med 2011
18
50

Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression.
Catarina Salgado, Celine Roelse, Rogier Nell, Nelleke Gruis, Remco van Doorn, Pieter van der Velden. PLoS One 2020
3
66

The non-canonical functions of telomerase: to turn off or not to turn off.
Aleksandra Romaniuk, Anna Paszel-Jaworska, Ewa Totoń, Natalia Lisiak, Hanna Hołysz, Anna Królak, Sylwia Grodecka-Gazdecka, Błażej Rubiś. Mol Biol Rep 2019
15
50

Telomerase directly regulates NF-κB-dependent transcription.
Arkasubhra Ghosh, Gaye Saginc, Shi Chi Leow, Ekta Khattar, Eun Myong Shin, Ting Dong Yan, Marc Wong, Zhizhuo Zhang, Guoliang Li, Wing-Kin Sung,[...]. Nat Cell Biol 2012
208
50

MDS shows a higher expression of hTERT and alternative splice variants in unactivated T-cells.
Wen Dong, Lei Wu, Houfang Sun, Xiubao Ren, Pearlie K Epling-Burnette, Lili Yang. Oncotarget 2016
5
50

Telomeres and telomerase in oncogenesis.
Tomasz Trybek, Artur Kowalik, Stanisław Góźdź, Aldona Kowalska. Oncol Lett 2020
9
50


Diverse regulatory manners of human telomerase reverse transcriptase.
Meng-Meng Jie, Xing Chang, Shuo Zeng, Cheng Liu, Guo-Bin Liao, Ya-Ran Wu, Chun-Hua Liu, Chang-Jiang Hu, Shi-Ming Yang, Xin-Zhe Li. Cell Commun Signal 2019
8
50


Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein.
Masaharu Akiyama, Teru Hideshima, Toshiaki Hayashi, Yu-Tzu Tai, Constantine S Mitsiades, Nicholas Mitsiades, Dharminder Chauhan, Paul Richardson, Nikhil C Munshi, Kenneth C Anderson. Cancer Res 2003
170
50

Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia.
Marzia Palma, Anton Parker, Mohammad Hojjat-Farsangi, Jade Forster, Parviz Kokhaei, Lotta Hansson, Anders Osterborg, Håkan Mellstedt. Exp Hematol 2013
13
50

Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer.
Ricardo Leão, Joana Dias Apolónio, Donghyun Lee, Arnaldo Figueiredo, Uri Tabori, Pedro Castelo-Branco. J Biomed Sci 2018
74
50

The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis.
Imke Listerman, Jie Sun, Francesca S Gazzaniga, Jason L Lukas, Elizabeth H Blackburn. Cancer Res 2013
98
50

Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types.
A Kilian, D D Bowtell, H E Abud, G R Hime, D J Venter, P K Keese, E L Duncan, R R Reddel, R A Jefferson. Hum Mol Genet 1997
496
50

Expression profile of a gamma-deletion variant of the human telomerase reverse transcriptase gene.
Hisashi Hisatomi, Kazuma Ohyashiki, Junko H Ohyashiki, Kumi Nagao, Taichi Kanamaru, Hiroyuki Hirata, Nozomu Hibi, Yutaka Tsukada. Neoplasia 2003
55
50


Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.
Cheryl M Koh, Ekta Khattar, Shi Chi Leow, Chia Yi Liu, Julius Muller, Wei Xia Ang, Yinghui Li, Guido Franzoso, Shang Li, Ernesto Guccione,[...]. J Clin Invest 2015
89
50

Non-canonical Roles of Telomerase: Unraveling the Imbroglio.
Evelyne Ségal-Bendirdjian, Vincent Geli. Front Cell Dev Biol 2019
21
50


CpG and Non-CpG Methylation in Epigenetic Gene Regulation and Brain Function.
Hyun Sik Jang, Woo Jung Shin, Jeong Eon Lee, Jeong Tae Do. Genes (Basel) 2017
120
25

Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
Young Shin Song, Jung Ah Lim, Hoonsung Choi, Jae-Kyung Won, Jae Hoon Moon, Sun Wook Cho, Kyu Eun Lee, Young Joo Park, Ka Hee Yi, Do Joon Park,[...]. Cancer 2016
87
25

Cancer epigenetics: Moving forward.
Angela Nebbioso, Francesco Paolo Tambaro, Carmela Dell'Aversana, Lucia Altucci. PLoS Genet 2018
138
25

Regulation of chromatin by histone modifications.
Andrew J Bannister, Tony Kouzarides. Cell Res 2011
25


The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
157
25

Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma.
Jee-Hye Choi, Soo Hyun Park, Jina Park, Borae G Park, Seong-Jae Cha, Kwang-Hoon Kong, Kwang-Ho Lee, Ae Ja Park. Biochem Biophys Res Commun 2007
27
25

High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation.
A Bounacer, R Wicker, B Caillou, A F Cailleux, A Sarasin, M Schlumberger, H G Suárez. Oncogene 1997
238
25

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease.
Martin Hysek, Johan O Paulsson, Kenbugul Jatta, Ivan Shabo, Adam Stenman, Anders Höög, Catharina Larsson, Jan Zedenius, Carl Christofer Juhlin. Cancers (Basel) 2019
18
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.